Latest Breaking News On - Poster coauthor - Page 1 : comparemela.com

- Preclinical and early clinical studies of MYMD-1, an oral, small-molecule, selective TNF-a inhibitor, suggest future potential to disrupt the Rheumatoid Arthritis market - MyMD Pharmaceuticals

United kingdomAndrea cohenLeonard dunnRobert schatzChristopher chapmanCompany annual report on formMymd pharmaceuticalsMymd pharmaceuticals incCompany quarterly reports on formBritish society for immunologySam brown incRheumatoid arthritisChief medical officerPoster coauthorStatement regarding forward looking statementsAnnual report